Marawan A. Elbaset

1.2k total citations
70 papers, 803 citations indexed

About

Marawan A. Elbaset is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Marawan A. Elbaset has authored 70 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Epidemiology and 10 papers in Pharmacology. Recurrent topics in Marawan A. Elbaset's work include Liver Disease Diagnosis and Treatment (11 papers), Liver physiology and pathology (8 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). Marawan A. Elbaset is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver physiology and pathology (8 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). Marawan A. Elbaset collaborates with scholars based in Egypt, Saudi Arabia and United States. Marawan A. Elbaset's co-authors include Rehab F. Abdel‐Rahman, Hanan A. Ogaly, Sherehan M. Ibrahim, Noha F. Abdelkader, Hany M. Fayed, Tuba Esatbeyoglu, Sally A. El Awdan, Sherif M. Afifi, Reham M. Abd‐Elsalam and Marwa M. Safar and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Marawan A. Elbaset

61 papers receiving 791 citations

Peers

Marawan A. Elbaset
Basim Anwar Shehata Messiha Egypt
Reem N. El‐Naga Egypt
Xin Jia China
Shohda A. El‐Maraghy Egypt
Kefeng Zhang China
Shangfu Xu China
Shiyun Pu China
Madhulika Tripathi Singapore
G Czechowska Poland
Basim Anwar Shehata Messiha Egypt
Marawan A. Elbaset
Citations per year, relative to Marawan A. Elbaset Marawan A. Elbaset (= 1×) peers Basim Anwar Shehata Messiha

Countries citing papers authored by Marawan A. Elbaset

Since Specialization
Citations

This map shows the geographic impact of Marawan A. Elbaset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marawan A. Elbaset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marawan A. Elbaset more than expected).

Fields of papers citing papers by Marawan A. Elbaset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marawan A. Elbaset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marawan A. Elbaset. The network helps show where Marawan A. Elbaset may publish in the future.

Co-authorship network of co-authors of Marawan A. Elbaset

This figure shows the co-authorship network connecting the top 25 collaborators of Marawan A. Elbaset. A scholar is included among the top collaborators of Marawan A. Elbaset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marawan A. Elbaset. Marawan A. Elbaset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdel‐Maksoud, Mohammed S., et al.. (2025). Design and synthesis of novel cyclohexanecarboxamides with anticonvulsant effect by activating Nrf2-ARE pathway. Bioorganic Chemistry. 159. 108357–108357. 1 indexed citations
2.
3.
4.
Bashandy, Samir A. E., et al.. (2025). Management of cardiovascular disease by cerium oxide nanoparticles via alleviating oxidative stress and adipokine abnormalities. Scientific Reports. 15(1). 5709–5709. 6 indexed citations
5.
Alsugoor, Mahdi H., Hany M. Fayed, Sherif M. Afifi, et al.. (2025). Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways. Frontiers in Pharmacology. 16. 1586231–1586231. 3 indexed citations
6.
Elbaset, Marawan A., et al.. (2024). Nrf2/HO‐1, NF‐κB and PI3K/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in rats. Journal of Cellular and Molecular Medicine. 28(3). e18116–e18116. 18 indexed citations
7.
Moussa, Sherif A. Abdelmottaleb, Marawan A. Elbaset, Sherif M. Afifi, et al.. (2024). The potency of Thymus vulgaris seed extract in alleviating obesity complications and iron overload in obese rats. Journal of Functional Foods. 121. 106416–106416. 1 indexed citations
8.
Elbaset, Marawan A., et al.. (2024). Optimizing bioavailability and antihypertensive activity of Carvedilol cubosomes using D-optimal design: Comparative analysis of Cremophor RH 40 and Polyvinyl alcohol as secondary stabilizers. Journal of Drug Delivery Science and Technology. 97. 105817–105817. 2 indexed citations
9.
Elbaset, Marawan A., et al.. (2024). Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway. Advances in Pharmacological and Pharmaceutical Sciences. 2024. 1–11. 5 indexed citations
10.
Attia, Hany G., et al.. (2023). Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches. Journal of Pharmacy & Pharmaceutical Sciences. 26. 11808–11808. 20 indexed citations
11.
El‐Seidy, Ahmed M. A., et al.. (2023). Nano cerium oxide and cerium/zinc nanocomposites characterization and therapeutic role in combating obesity via controlling oxidative stress and insulin resistance in rat model. Journal of Trace Elements in Medicine and Biology. 80. 127312–127312. 13 indexed citations
12.
Elbaset, Marawan A., et al.. (2023). Erythropoietin Suppresses the Hepatic Fibrosis Caused by Thioacetamide: Role of the PI3K/Akt and TLR4 Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2023. 1–14. 17 indexed citations
13.
Abdel‐Rahman, Rehab F., Hany M. Fayed, Marawan A. Elbaset, et al.. (2023). Apigenin role against thioacetamide-triggered liver fibrosis: Deciphering the PPARγ/TGF-β1/NF-κB and the HIF/FAK/AKT pathways. Journal of Herbmed Pharmacology. 12(2). 202–213. 16 indexed citations
14.
Ibrahim, Bassant M. M., et al.. (2023). A pharmacological and toxicological biochemical study of cardiovascular regulatory effects of hibiscus, corn silk, marjoram, and chamomile. Heliyon. 10(1). e22659–e22659. 6 indexed citations
15.
Bashandy, Samir A. E., Hossam Ebaid, Jameel Al‐Tamimi, et al.. (2023). Protective Effect of Daidzein against Diethylnitrosamine/Carbon Tetrachloride-Induced Hepatocellular Carcinoma in Male Rats. Biology. 12(9). 1184–1184. 5 indexed citations
16.
Moussa, Sherif A. Abdelmottaleb, Samir A. E. Bashandy, Marawan A. Elbaset, et al.. (2023). Role of Goldenberry (Fruits with Husk) Extract in Ameliorating the Architecture and Osmotic Fragility of Red Blood Cells in Obese Rats. BioMed Research International. 2023(1). 8794214–8794214. 3 indexed citations
17.
Abdelkader, Noha F., et al.. (2022). Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling. Archives of Pharmacal Research. 45(7). 475–493. 35 indexed citations
18.
19.
Abdel‐Rahman, Rehab F., Hany M. Fayed, Gihan F. Asaad, et al.. (2021). The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats. PLoS ONE. 16(12). e0260130–e0260130. 37 indexed citations
20.
Abdel‐Rahman, Rehab F., et al.. (2017). Antihypertensive Effects of Roselle‐Olive Combination in L‐NAME‐Induced Hypertensive Rats. Oxidative Medicine and Cellular Longevity. 2017(1). 9460653–9460653. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Basim Anwar Shehata Messiha Breakdown of academic impact, for papers by Reem N. El‐Naga Breakdown of academic impact, for papers by Xin Jia Breakdown of academic impact, for papers by Shohda A. El‐Maraghy Breakdown of academic impact, for papers by Kefeng Zhang Breakdown of academic impact, for papers by Shangfu Xu Breakdown of academic impact, for papers by Shiyun Pu Breakdown of academic impact, for papers by Madhulika Tripathi Breakdown of academic impact, for papers by G Czechowska
Rankless by CCL
2026